Global Tissue Engineering and Regeneration Market Set to Surge at 12.8% CAGR Through 2030 “Fueled by the growing burden of chronic diseases, increased research activity, and strong venture capital support, the market is rapidly evolving with innovations in biomaterials, scaffolds, and regenerative therapies, offering strategic opportunities for companies worldwide.” GlobeNewswire August 19, 2025 Boston, Aug. […]

Kasisto, the market leader for AI in banking, today launched KAIgentic, an agentic AI platform purpose built for banking and now available to banks and credit unions. KAIgentic delivers AI that thinks like a bank's best banker, combining intelligence, compliance, and bank grade performance in one platform across customer experience, employee experience, and AI operations.

National plaintiffs' law firm Berger Montague PCis investigating securities fraud claims againstSpectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) (“Spectrum” or the “Company”) on behalf of investors who purchased or otherwise acquired common shares of Spectrum betweenMarch 17, 2022 through September 22, 2022 (the “Class Period”). https://mma.prnewswire.com/media/232479/berger_montague.jpg Investor Deadline:Investors who purchased or acquired Spectrum securities during the Class

NEW YORK, NY / ACCESS Newswire / August 19, 2025 / If you suffered a loss on your Hims & Hers Health, Inc. (NYSE:HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/hims-hers-health-inc-lawsuit-submission-form?prid=162373&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at

“In 1986, while attending Smithsonian institute in Parkhill Denver, CO, I succeeded most recreational events through fasting and utilizing import herbs known to thrive in the USA,” said an inventor, from Lakewood, Colo. “The non-narcotic organic imports contained (API) which aided in remedying azmatic refluxes, until the symptoms had dissolved. Later I was able to

DeepSight Technology, a pioneer in medical imaging, today announced the appointment of Steve Sapot as its new Vice President of Sales. In this role, Mr. Sapot will spearhead the company's commercial strategy, driving market adoption, partnerships, and customer engagement for DeepSight's cutting-edge ultrasound solutions, including the NeedleVue™ LC1 Ultrasound System that will work in tandem

Slayton joins as President following recent investment as company expands market presence and strengthens its leading back-of-house restaurant operations software platform Rosnet, a leading back-of-house restaurant management platform, today announced the appointment of Derek Slayton as President, effective immediately. Following the recent strategic investment in Rosnet by M33 Growth, Slayton has joined the company to

National plaintiffs' law firm Berger Montague PCannounces a class action lawsuit against CTO Realty Growth, Inc. (NYSE: CTO) (“CTO” or the “Company”) on behalf of investors who purchased or otherwise acquired publicly traded securities of CTO between February 18, 2021 through June 24, 2025 (the “Class Period”). https://mma.prnewswire.com/media/232479/berger_montague.jpg Investor Deadline:Investors who purchased or acquired CTO

(NASDAQ:SLNO), ATLANTA, Aug. 19, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether Soleno Therapeutics, Inc. (“Soleno Therapeutics” or the “Company”) (NASDAQ: SLNO) complied with federal securities laws. On August 15, 2025, Scorpion Capital released a report alleging, among other things, that Soleno Therapeutics' phase 3 clinical trials and withdrawal studies conducted in

INVESTOR ALERT: Investigation of Soleno Therapeutics, Inc. (SLNO) Announced by Holzer & Holzer, LLC GlobeNewswire August 19, 2025 ATLANTA, Aug. 19, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether Soleno Therapeutics, Inc. (“Soleno Therapeutics” or the “Company”) (NASDAQ: SLNO) complied with federal securities laws. On August 15, 2025, Scorpion Capital released a